Synergic activity of oligostyrylbenzenes with amphotericin B against Candida tropicalis biofilms.
Melisa A QuinterosJuan TolosaJoaquín C García-MartínezPaulina Laura PáezMaría Gabriela ParajePublished in: Yeast (Chichester, England) (2021)
Antimicrobial drug resistance is a serious challenge in clinical settings worldwide, with biofilm formation having been associated with this problem. In the present study, the synergism of oligostyrylbenzene (OSB) compounds in combination with amphotericin B (AmB) against Candida tropicalis biofilms was investigated. In addition, the toxicity in human blood cells was determined. Synergistic combinations of OSBs and AmB were evaluated to consider future effects of OSBs in vivo. The checkerboard microdilution method was used to study the interactions of one anionic (1) and two cationic (2 and 3) OSBs with AmB. We investigated the effects of OSBs on reactive oxygen species (ROS) and the levels of the reactive nitrogen intermediates (RNIs). The cellular stress affected biofilm growth through an accumulation of ROS and RNI, at synergistic concentrations of OSBs and AmB. Furthermore, significant surface topography differences were noted upon treatment with the OSB 2/AmB combination, using confocal laser scanning microscopy in conjunction with the image analysis software COMSTAT. The results revealed a low toxicity to leukocytes and red blood cells at synergistic combinations of cationic OSBs with AmB. These findings demonstrated the antibiofilm effects of OSBs and the synergism of AmB with cationic OSBs against biofilms of C. tropicalis for the first time.
Keyphrases
- candida albicans
- biofilm formation
- reactive oxygen species
- staphylococcus aureus
- pseudomonas aeruginosa
- red blood cell
- cell death
- escherichia coli
- cancer therapy
- endothelial cells
- high resolution
- oxidative stress
- optical coherence tomography
- induced apoptosis
- single molecule
- signaling pathway
- high speed
- cystic fibrosis
- endoplasmic reticulum stress
- peripheral blood
- cell cycle arrest
- mass spectrometry
- pluripotent stem cells
- replacement therapy
- combination therapy